Similarly, in mice with tumors derived from injection of mouse colon cancer C26 cells, treatment with a combination of anti-VEGFR2 and anti-PD-1 monoclonal antibodies led to enhanced inhibition of tumor growth compared with either treatment alone [93]. This evidence concerns the gene KDR and neoplasm.